iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
10/11/2011 11:14:27 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--iScience Interventional (iScience, Menlo Park, CA), pioneers of site-specific therapies for anterior and posterior ocular diseases, today announced an investment by Medtronic Inc. to support rapidly expanding commercialization activities and the development of innovative drug delivery technologies for the eye. iScience Interventional is the world leader in developing minimally invasive access technologies that are used to deliver drugs, biologics, and devices to difficult to reach locations within the eye.
comments powered by